MEDCAW INVESTMENTS LS-01
Medcaw Investments Plc does not have significant operations. It focuses on identifying acquisition opportunities. The company was incorporated in 2020 and is based in London, the United Kingdom.
Market Cap & Net Worth: MEDCAW INVESTMENTS LS-01 (U09)
MEDCAW INVESTMENTS LS-01 (F:U09) has a market capitalization of $624.74K (€608.63K) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #38621 globally and #5295 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDCAW INVESTMENTS LS-01's stock price €0.03 by its total outstanding shares 22132095 (22.13 Million).
MEDCAW INVESTMENTS LS-01 Market Cap History: 2023 to 2026
MEDCAW INVESTMENTS LS-01's market capitalization history from 2023 to 2026. Data shows change from $920.08K to $624.74K (-35.77% CAGR).
MEDCAW INVESTMENTS LS-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDCAW INVESTMENTS LS-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of U09 by Market Capitalization
Companies near MEDCAW INVESTMENTS LS-01 in the global market cap rankings as of March 18, 2026.
Key companies related to MEDCAW INVESTMENTS LS-01 by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #131 globally with a market cap of $139.78 Billion USD.
- Blackstone Group Inc (NYSE:BX): Ranked #245 globally with a market cap of $83.28 Billion USD.
- INVESTOR B (FRIA) O.N. (F:IVSD): Ranked #246 globally with a market cap of $83.12 Billion USD ( €80.97 Billion EUR).
- Brookfield Corp (NYSE:BN): Ranked #276 globally with a market cap of $76.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | BlackRock Inc | NYSE:BLK | $139.78 Billion | $971.01 |
| #245 | Blackstone Group Inc | NYSE:BX | $83.28 Billion | $112.00 |
| #246 | INVESTOR B (FRIA) O.N. | F:IVSD | $83.12 Billion | €33.16 |
| #276 | Brookfield Corp | NYSE:BN | $76.43 Billion | $39.71 |
MEDCAW INVESTMENTS LS-01 Historical Marketcap From 2023 to 2026
Between 2023 and today, MEDCAW INVESTMENTS LS-01's market cap moved from $920.08K to $ 624.74K, with a yearly change of -35.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €624.74K | 0.00% |
| 2025 | €624.74K | -32.10% |
| 2024 | €920.08K | 0.00% |
| 2023 | €920.08K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MEDCAW INVESTMENTS LS-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $624.74K USD |
| MoneyControl | $624.74K USD |
| MarketWatch | $624.74K USD |
| marketcap.company | $624.74K USD |
| Reuters | $624.74K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.